BMS Pharmaceutical's Baraclude 0.5mg recorded no.1 in import of drug product last year

According to Korea Pharmaceutical Traders Association, BMS Pharmaceutical's Baraclude 0.5mg recorded no.1 in import of drug product last year.

Baraclude 0.5mg recorded import of $ 8.183 million, followed by MSD's Gadacil $ 5.943 million, Pfizer Korea's pneumococcal vaccine Prevenar $ 4.929 millon, Roche Korea's Herceptin 150mg $ 4.703 million, AstraZeneca's Crestor 10mg $ 4,378 million, Novart...